Comparison Overview

Medacta Germany

VS

BD

Medacta Germany

Jahnstraße 86, Göppingen, Baden-Württemberg 73037, DE
Last Update: 2025-03-16 (UTC)
Between 750 and 799

Medacta Germany ist eine Niederlassung von Medacta International, einem Unternehmen, das sich auf das Design, die Produktion und den Vertrieb von innovativen orthopädischen Produkten sowie auf die Entwicklung von begleitenden Operationstechniken spezialisiert hat. Gegründet 1999 in der Schweiz, ist Medacta in den Bereichen Gelenkersatz, Wirbelsäulenchirurgie und Sportmedizin tätig. Medacta setzt sich für die Verbesserung der Versorgung und des Wohlbefindens von Patienten ein und legt einen starken Fokus auf die Nachhaltigkeit im Gesundheitswesen. Die Innovationen von Medacta, die in enger Zusammenarbeit mit führenden Chirurgen weltweit entstanden sind, begannen mit minimal-invasiven Operationstechniken und entwickelten sich zu personalisierten Lösungen für jeden Patienten weiter. Durch das M.O.R.E. Institut unterstützt Medacta Chirurgen mit einem umfassenden und maßgeschneiderten Programm, das der Förderung der medizinischen Ausbildung dient. Medacta hat seinen Hauptsitz in Castel San Pietro, Schweiz, und ist in über 40 Ländern tätig.

NAICS: 339
NAICS Definition:
Employees: 0
Subsidiaries: 7
12-month incidents
0
Known data breaches
0
Attack type number
0

BD

1 Becton Drive, Franklin Lakes, New Jersey, 07417, US
Last Update: 2025-03-04 (UTC)
Between 800 and 849

BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 43,786
Subsidiaries: 6
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/defaultcompany.jpeg
Medacta Germany
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/bd1.jpeg
BD
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Medacta Germany
100%
Compliance Rate
0/4 Standards Verified
BD
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Medacta Germany in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for BD in 2025.

Incident History — Medacta Germany (X = Date, Y = Severity)

Medacta Germany cyber incidents detection timeline including parent company and subsidiaries

Incident History — BD (X = Date, Y = Severity)

BD cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/defaultcompany.jpeg
Medacta Germany
Incidents

No Incident

https://images.rankiteo.com/companyimages/bd1.jpeg
BD
Incidents

No Incident

FAQ

BD company demonstrates a stronger AI Cybersecurity Score compared to Medacta Germany company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, BD company has disclosed a higher number of cyber incidents compared to Medacta Germany company.

In the current year, BD company and Medacta Germany company have not reported any cyber incidents.

Neither BD company nor Medacta Germany company has reported experiencing a ransomware attack publicly.

Neither BD company nor Medacta Germany company has reported experiencing a data breach publicly.

Neither BD company nor Medacta Germany company has reported experiencing targeted cyberattacks publicly.

Neither Medacta Germany company nor BD company has reported experiencing or disclosing vulnerabilities publicly.

Neither Medacta Germany nor BD holds any compliance certifications.

Neither company holds any compliance certifications.

Medacta Germany company has more subsidiaries worldwide compared to BD company.

BD company employs more people globally than Medacta Germany company, reflecting its scale as a Medical Equipment Manufacturing.

Neither Medacta Germany nor BD holds SOC 2 Type 1 certification.

Neither Medacta Germany nor BD holds SOC 2 Type 2 certification.

Neither Medacta Germany nor BD holds ISO 27001 certification.

Neither Medacta Germany nor BD holds PCI DSS certification.

Neither Medacta Germany nor BD holds HIPAA certification.

Neither Medacta Germany nor BD holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

The Bold Page Builder plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the ‘percentage’ parameter in all versions up to, and including, 5.4.5 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers, with Contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.

Risk Information
cvss3
Base: 6.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
Description

The ComboServlet in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0 through 2023.Q4.2, 2023.Q3.1 through 2023.Q3.5, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions does not limit the number or size of the files it will combine, which allows remote attackers to create very large responses that lead to a denial of service attack via the URL query string.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and create arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary files on the target machine.

Risk Information
cvss3
Base: 7.5
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:H
cvss4
Base: 8.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:H/SC:N/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X